Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kooi Yeong Khaw, Chun Wie Chong & Vikneswaran Murugaiyah. (2020) LC-QTOF-MS analysis of xanthone content in different parts of Garcinia mangostana and its influence on cholinesterase inhibition. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1433-1441.
Read now
Read now
Ayesha Khan, Anne Corbett & Clive Ballard. (2017) Emerging amyloid and tau targeting treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics 17:7, pages 697-711.
Read now
Read now
Ayesha Khan, Anne Corbett & Clive Ballard. (2017) Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets. Expert Review of Neurotherapeutics 17:7, pages 683-695.
Read now
Read now
Faizul Azam, Abdualrahman M Amer, Abdullah R Abulifa & Mustafa M Elzwawi. (2014) Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer’s drugs: a computational investigation. Drug Design, Development and Therapy 8, pages 2045-2059.
Read now
Read now
Articles from other publishers (6)
Jianwen Sheng, Shanjin Zhang, Lule Wu, Gajendra Kumar, Yuanhang Liao, Pratap GK & Huizhen Fan. (2022) Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Liang Gu, Nan Cai, Meiting Li, Decheng Bi, Lijun Yao, Weishan Fang, Yan Wu, Zhangli Hu, Qiong Liu, Zhijian Lin, Jun Lu & Xu Xu. (2022) Inhibitory Effects of Macelignan on Tau Phosphorylation and Aβ Aggregation in the Cell Model of Alzheimer's Disease. Frontiers in Nutrition 9.
Crossref
Crossref
Márcia Martins, Renata Silva, Madalena M. M. Pinto & Emília Sousa. (2020) Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease. Pharmaceuticals 13:9, pages 242.
Crossref
Crossref
Bi-Wen Chen, Wen-Xing Li, Guang-Hui Wang, Gong-Hua Li, Jia-Qian Liu, Jun-Juan Zheng, Qian Wang, Hui-Juan Li, Shao-Xing Dai & Jing-Fei Huang. (2018) A strategy to find novel candidate anti-Alzheimer’s disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants. PeerJ 6, pages e4756.
Crossref
Crossref
Shu-Ping Li, Yu-Wen Wang, Sheng-Lan Qi, Yun-Peng Zhang, Gang Deng, Wen-Zheng Ding, Chao Ma, Qi-Yan Lin, Hui-Da Guan, Wei Liu, Xue-Mei Cheng & Chang-Hong Wang. (2018) Analogous β-Carboline Alkaloids Harmaline and Harmine Ameliorate Scopolamine-Induced Cognition Dysfunction by Attenuating Acetylcholinesterase Activity, Oxidative Stress, and Inflammation in Mice. Frontiers in Pharmacology 9.
Crossref
Crossref
Lingli Yan, Yuanyuan Deng, Jianmei Gao, Yuangui Liu, Fei Li, Jingshan Shi & Qihai Gong. (2017) Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer’s Disease Model Mice Targeting Beta-Amyloid Production. Frontiers in Pharmacology 8.
Crossref
Crossref